NewAmsterdam Pharma Corporation

NewAmsterdam Pharma is a clinical-stage biopharmaceutical company focused on developing transformative oral therapies for patients with metabolic diseases. Their lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), aiming to reduce low-density lipoprotein cholesterol (LDL-C) while increasing high-density lipoprotein cholesterol (HDL-C). The company is driven by a robust scientific approach rooted in the genetic link between CETP and metabolic diseases, with clinical trial results showing significant reductions in LDL-C and positive impacts on HDL-C.

NewAmsterdam is backed by a strong management team of industry veterans and experts in cardiometabolic fields, and the company is supported by a well-established board of directors with extensive experience in biotechnology, finance, and healthcare. They are actively engaged in Phase 3 trials for obicetrapib across various indications, including cardiovascular disease, familial hypercholesterolemia, and Alzheimer's disease. NewAmsterdam's commitment to developing safe and effective treatments, along with their comprehensive scientific approach, positions them as a key player in the future of metabolic disease treatment.

NewAmsterdam Pharma offers a remote work arrangement for the Manager/Senior Manager, Quality position. While some travel may be required, the company promotes flexible working arrangements and values work-life balance.

NewAmsterdam Pharma offers a comprehensive benefits package to its employees, including health insurance, dental and vision coverage, term life and disability coverage, retirement plans, and stock option awards.

NewAmsterdam Pharma Corporation is a clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients with metabolic diseases, particularly those with dyslipidemia and cardiovascular disease. They are focused on providing safe and convenient oral medications that can effectively lower LDL cholesterol and raise HDL cholesterol levels, ultimately aiming to transform the treatment paradigm for these patients and improve their overall health outcomes.

NewAmsterdam Pharma fosters a passionate, supportive culture that values integrity and inclusivity. They are led by a team of industry veterans and key opinion leaders, creating an environment of expertise and mentorship. This dynamic, high-performing team is driven by a shared commitment to advancing life-saving treatments and improving patient lives.

NewAmsterdam Pharma Corporation fosters a passionate, supportive culture characterized by a high level of integrity and inclusivity. The company is committed to creating an equitable and inclusive workplace where all employees feel valued, respected, and empowered to contribute their unique talents and perspectives. They strive to build a diverse workforce that reflects the communities they serve and are dedicated to promoting opportunities for advancement and professional development for all employees.